MedTrace Logo

Bilateral Refractive Amblyopia Treatment Study

NCT00305955 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2010-03-24

No results posted yet for this study

Summary

The purpose of this study will be to:

* Determine the amount of visual acuity improvement with treatment of presumed bilateral refractive amblyopia
* Determine the time course of visual acuity improvement with treatment

Conditions

  • Bilateral Refractive Amblyopia

Interventions

DEVICE

Spectacles

optimal spectacle correction

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Jaeb Center for Health Research

    lead OTHER

Principal Investigators

  • David K. Wallace, M.D. · Duke University Eye Center

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2006-07-31
Completion
2006-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00305955 on ClinicalTrials.gov